New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
NCT ID NCT07614958
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called obicetrapib against another drug, bempedoic acid, to see which lowers 'bad' cholesterol more effectively. It involves 426 adults with high cholesterol who are already on maximum cholesterol medications and are at high risk for heart problems. The goal is to find a better option to control cholesterol and reduce heart disease risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
FutureMeds North Tees
RECRUITINGStockton-on-Tees, TS19, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo pill aims to supercharge cholesterol lowering
- New cholesterol combo pill aims to slash bad cholesterol without prior meds
- One shot to tackle two heart risks? new combo drug enters human trials
- Are cholesterol patients getting the right care? new study aims to find out
- Plant power: natural extract shows promise for high cholesterol
- New injection shows promise for lowering cholesterol in indian patients